Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response

Archive ouverte

Geoffroy, Pierre, Alexis | Etain, Bruno | Sportiche, Sarah | Bellivier, Frank

Edité par CCSD ; Springer Open -

International audience. Bipolar disorder (BD) is a common, severe mental disorder with a high recurrence rate. Lithium (Li) is the cornerstone of BD treatments to reduce recurrence, suicide, and mortality risks. However, only 30% of patients treated with Li achieve complete remission, and few markers of the response to treatment have yet been identified for application in routine practice. Circadian biomarkers may be relevant predictors of individual responses to Li because (1) Li has been shown to affect circadian rhythms, (2) disrupted circadian rhythms are a core expression of susceptibility to BD, and (3) circadian abnormalities during euthymia are associated with relapses.

Suggestions

Du même auteur

Combination therapy for manic phases: a critical review of a common practice.

Archive ouverte | Geoffroy, Pierre Alexis | CCSD

International audience. All relevant guidelines recommend monotherapy as the initial treatment for manic phases of bipolar disorder (BD), with combination therapy reserved for severe cases or as a subsequent choice....

Can the response to mood stabilizers be predicted in bipolar disorder?

Archive ouverte | Geoffroy, Pierre Alexis | CCSD

International audience. Bipolar disorder (BD) is a severe chronic multifactorial disease that requires maintenance therapy with mood stabilizers (MS). Even with medications, the rate of response among patients with ...

[Treatment of manic phases of bipolar disorder: Critical synthesis of international guidelines.]

Archive ouverte | Geoffroy, Pierre Alexis | CCSD

International audience. INTRODUCTION: Bipolar disorder (BD) is the seventh leading cause of disability per year of life among all diseases in the population aged 15 to 44. It is a group of heterogeneous diseases, wi...

Chargement des enrichissements...